TOIIW
NASDAQ
$0.07
Oncology Institute Inc (The) - Warrants (15/11/2026) (TOIIW)
The Oncology Institute Inc. (TOIIW) is a prominent provider of specialized cancer care, dedicated to delivering high-quality and accessible treatment through an extensive network of outpatient facilities. The company emphasizes innovative therapies and a patient-centered approach, aiming to enhance clinical outcomes and improve the overall patient experience amid the increasing demand for specialized oncology services. With a robust strategy for growth and market penetration, The Oncology Institute represents a compelling opportunity for institutional investors looking to invest in the evolving cancer care landscape.
This company is also listed under the following ticker: TOI.
Website: https://theoncologyinstitute.comBeta (5Y)
2.85
Price Chart
Profitability
Total Revenue (TTM)$461M
EBITDA-$34M
Profit Margin-14.4%
Operating Margin-5.9%
EPS-$602.09
Growth & Risk
Beta (5Y)2.85
Sharpe Ratio1.09